China Digest: Cure Genetics nets $60m; Atom Bioscience raises over $47m

Photo by Hal Gatewood on Unsplash

Chinese biotech startup Cure Genetics has secured $60 million in a Series B round. Separately, the country’s pharmaceutical firm Atom Bioscience has raised over 300 million yuan ($47.2 million) to fund the clinical development of its drug candidates.

Qiming-backed biotech startup Cure Genetics nets $60m

Cure Genetics, a Chinese biotech startup that focuses on the treatment of cancers and genetic diseases, has secured $60 million in a Series B round of financing led by China-focused private equity (PE) firm Advantech Capital.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter